JW Lifescience Corporation

KRX:234080.KS

10940 (KRW) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q2
Revenue 54,397.33255,334.23653,637.44151,141.24452,089.69149,991.99650,242.73347,726.57647,125.61743,836.23944,424.6240,237.96942,727.04742,427.31444,646.41746,339.72347,561.83146,291.01844,574.8143,097.6941,973.69840,574.58139,148.24440,267.86936,842.51138,971.42837,987.20537,587.31933,785.20334,240.12133,621.09731,576.85933,861.433,231.04930,427.16131,703.81734,894.844
Cost of Revenue 40,508.44341,239.68940,017.61739,249.91638,973.78336,449.64337,207.84437,098.47534,554.46631,949.6832,124.34329,243.92629,744.14929,547.25229,289.57131,898.5932,198.51931,955.40532,413.94530,982.60429,390.00328,728.10428,412.67329,891.29426,495.70430,915.71229,166.93828,368.33624,353.85924,530.63625,855.04823,133.66325,213.70723,809.56522,130.18325,117.35826,655.466
Gross Profit 13,888.88914,094.54713,619.82411,891.32813,115.90813,542.35313,034.88910,628.10112,571.15111,886.55912,300.27710,994.04312,982.89812,880.06215,356.84514,441.13215,363.31114,335.61312,160.86512,115.08612,583.69511,846.47710,735.57110,376.57510,346.8078,055.7168,820.2679,218.9839,431.3449,709.4857,766.0498,443.1968,647.6939,421.4848,296.9786,586.4598,239.378
Gross Profit Ratio 0.2550.2550.2540.2330.2520.2710.2590.2230.2670.2710.2770.2730.3040.3040.3440.3120.3230.310.2730.2810.30.2920.2740.2580.2810.2070.2320.2450.2790.2840.2310.2670.2550.2840.2730.2080.236
Reseach & Development Expenses 1,185.924958.4741,732.2771,352.4691,029.8691,046.5281,339.2691,540.0141,632.2651,225.1461,891.9661,462.4041,591.2761,295.9681,035.0271,301.6121,338.6131,520.2461,057.7961,141.2951,042.587342.4397.436210.073361.907166.002117.0671.791133.14877.417242.002153.9128.719140.042113.339115.858104.344
General & Administrative Expenses 5,701.478774.804796.2445,658.7685,334.484,679.08672.167107.38295.78290.05488.07298.767103.1274.71495.236101.205136.829101.047121.941185.052209.429114.295172.193206.632794.156210.668303.21245.224673.392188.658156.175259.688612.952248.552376.943284.784659.2
Selling & Marketing Expenses -1,408.0341,981.4841,968.139001,655.1012,242.3392,002.5022,004.8492,146.7122,095.2761,833.0312,265.9851,732.7812,232.791,645.5991,707.5481,604.452,081.181,895.071,874.9781,655.0851,907.2691,353.0411,183.2611,632.1922,224.5421,204.7631,225.5781,566.4811,822.9281,379.8251,344.1581,429.242,338.4921,008.914990.309
SG&A 4,293.4444,383.9363,871.1915,658.7685,334.484,679.0862,314.5062,109.8842,100.6312,236.7662,183.3481,931.7982,369.1051,807.4952,328.0261,746.8041,844.3771,705.4972,203.1212,080.1222,084.4071,769.382,079.4621,559.6731,977.4171,842.862,527.7521,449.9871,898.971,755.1391,979.1031,639.5131,957.111,677.7922,715.4351,293.6981,649.509
Other Expenses -29.16-151.098-31.69662.315-10,668.959-1,046.5281,468.4681,681.532252.364142.238284.406161.495186.47870.125154.503211.942160.835-1.727130.267162.757144.406116.079113.59192.50693.61384.893-70.38541.186-13.99195.50752.8489.66-18.08477.696-211.02558.82723.554
Operating Expenses 5,508.5285,493.5085,635.1645,658.768-5,334.4794,679.0865,122.2435,331.435,527.8755,049.8985,659.7724,969.6985,522.9934,588.1064,950.2734,931.4985,057.5365,107.0525,078.6445,015.114,936.3013,927.1064,200.5323,189.7584,612.313,970.7544,142.0512,878.7853,186.9313,195.9143,403.343,029.1693,227.8482,987.7493,772.3122,407.0042,717.751
Operating Income 8,380.368,601.0397,984.666,232.5597,781.4298,863.2677,912.6451,242.9587,043.2766,836.6616,640.5066,024.3457,459.9058,291.95410,406.5739,509.63110,305.7759,228.567,082.2227,099.9747,647.3947,919.3726,535.0387,186.8175,734.4964,084.9644,678.2166,340.1996,244.4136,513.5734,362.7095,414.0275,419.8446,433.7344,524.6674,179.4545,521.627
Operating Income Ratio 0.1540.1550.1490.1220.1490.1770.1570.0260.1490.1560.1490.150.1750.1950.2330.2050.2170.1990.1590.1650.1820.1950.1670.1780.1560.1050.1230.1690.1850.190.130.1710.160.1940.1490.1320.158
Total Other Income Expenses Net -385.357-270.3524,088.577-386.711-618.4672.782-1,239.5562,537.451-2,810.292-741.299-2,535.765-1,045.498-5,669.637-878.706-14,905.854-1,217.734-152.275-434.268-145.124-509.281-339.63-423.693-843.705-479.971-474.822-432.118-621.867-523.757-628.798-509.094-573.47-582.735-600.331-654.981-795.469-527.649-626.472
Income Before Tax 7,995.0048,330.68612,073.2375,845.8487,163.0299,536.0496,673.0893,780.4094,232.9846,095.3634,104.744,978.8471,790.2687,413.248-4,499.2818,291.89810,153.58,794.2926,937.0986,590.6927,307.7657,495.6795,691.3346,706.8465,259.6743,652.8464,056.3495,816.4425,615.6156,004.4793,789.2384,831.2924,819.5135,778.7533,729.1993,651.8054,895.155
Income Before Tax Ratio 0.1470.1510.2250.1140.1380.1910.1330.0790.090.1390.0920.1240.0420.175-0.1010.1790.2130.190.1560.1530.1740.1850.1450.1670.1430.0940.1070.1550.1660.1750.1130.1530.1420.1740.1230.1150.14
Income Tax Expense 723.7542,532.201898.6271,291.7481,498.8431,875.0842,098.578958.4321,301.7371,461.8312,358.3821,039.799109.551,865.7531,044.833308.3642,234.8461,852.3131,810.1451,490.6311,461.4491,630.571,136.9981,487.9182,194.605670.215959.591,289.981,224.3851,236.217794.6211,063.0061,036.5621,162.998480.245802.9921,069.67
Net Income 6,656.9675,133.02910,264.7154,554.15,664.1877,660.9644,574.5112,821.9772,931.2474,633.5321,746.3573,939.0481,680.7185,547.495-5,544.1147,983.5347,918.6546,941.9795,126.9535,100.0615,846.3165,865.1094,554.3365,218.9273,065.072,982.6313,096.7594,526.4634,391.234,768.2622,994.6183,768.2853,782.954,615.7553,248.9532,848.8133,825.485
Net Income Ratio 0.1220.0930.1910.0890.1090.1530.0910.0590.0620.1060.0390.0980.0390.131-0.1240.1720.1660.150.1150.1180.1390.1450.1160.130.0830.0770.0820.120.130.1390.0890.1190.1120.1390.1070.090.11
EPS 429.91331.49662.9294.11365.8494.75295.42182.24189.3297.4114252107350-350.47504500438323322369370287330194188.598143138.5301189238239291.5205.5180241.5
EPS Diluted 429.91331.49662.9294.11365.8494.75295.42182.24189297114252107350-350.47504500438323322369370287330194188.598143138.5301189238239291.5205.5180241.5
EBITDA 12,293.91112,513.35711,901.0910,147.06313,115.90813,542.35314,261.5744,968.10610,105.1769,940.9458,044.1258,705.7339,934.8910,880.9977,885.88712,764.62313,55112,254.66410,345.54510,143.28910,550.89510,805.0279,037.8089,961.7578,643.3617,024.8447,481.939,172.6688,977.39,336.8547,135.8349,221.18,826.4679,749.3047,610.987,378.1675,633.39
EBITDA Ratio 0.2260.2260.2220.1980.2520.2710.2840.1040.2140.2270.1810.2160.2330.2560.1770.2750.2850.2650.2320.2350.2510.2660.2310.2470.2350.180.1970.2440.2660.2730.2120.2920.2610.2930.250.2330.161